[Japon] Oral drug molnupiravir seen as ‘trump card’ in Japan’s battle against COVID-19
Auteur : Osamu Tsukimori. Staff writer de The Japan Times.
Production : The Japan Times
Diffusion : site de The Japan Times
Date : 20 octobre 2021
The government has expressed interest in introducing an oral antiviral drug for COVID-19 by the end of the year, with Prime Minister Fumio Kishida saying that such treatments could become a “key trump card” in the prolonged, uphill battle against the coronavirus.
Source : Osamu Tsukimori, « Oral drug molnupiravir seen as ‘trump card’ in Japan’s battle against COVID-19 », The Japan Times, 20/10/2021. URL : https://www.japantimes.co.jp/news/2021/10/20/national/molnupiravir-coronavirus-oral-drugs-explainer/ (consulté le 21/10/2021)
Photo « à la une » : An experimental antiviral pill developed by Merck & Co. © MERCK & CO. / VIA REUTERS